Renowned Immunotherapy Expert Dr. Michael Kalos Joins Anocca’s Scientific Advisory Board

Södertälje, Sweden, 7th April 2022 – Anocca, a biotechnology company using its precision biology platforms to engineer a broad portfolio of innovative T cell therapeutics, today announced the appointment of Dr. Michael Kalos to its Scientific Advisory Board (SAB).

Read the full release here.